跳至主要内容
临床试验/PACTR202202585571226
PACTR202202585571226尚未招募1 期

Application of bioactive peptide supplementation for attenuation of malnutrition in cancer patients in a treatment health facility in Ghana

South China University of Technology0 个研究点目标入组 80 人开始时间: 2022年2月14日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Only those who will meet all of the following criteria will be eligible to be included in the study:
  • 1. Histological confirmation of a newly diagnosed primary tumor
  • 2. Patient BMI < 18 kg/m2;
  • 3. Patients who received conventional radiotherapy or radiotherapy combined with chemotherapy after surgery;
  • 4. Nutritional assessment results before chemotherapy showing malnutrition;
  • 5. ECOG score 0-2;
  • 6. Sign the informed consent voluntarily.

排除标准

  • Those who meet any of the following criteria shall not be admitted to the study:
  • 1. Frequent vomiting or conditions affecting oral administration (e.g., the patient has intestinal obstruction)
  • 2. Pregnant or lactating women
  • 3. Any other conditions that the investigator considers unsuitable for inclusion in the study, if the subject's compliance is known to be poor

研究者

发起方
South China University of Technology

相似试验